Upsher-Smith Laboratories

Upsher-Smith Laboratories, LLC is a century-old American pharmaceutical company based in Maple Grove, Minnesota that brings brands and generics to a wide array of customers. Upsher-Smith is a part of Japan-based Sawai Group Holdings Co., Ltd.

Upsher-Smith Laboratories
TypePublicly traded
Founded1919; 104 years ago (1919) in Wayzata, Minnesota
HeadquartersMaple Grove, Minnesota, United States,
United States
Key people
  • Taku Nakaoka Chief Executive Officer and Chairman[1]
  • Rich Fisher Chief Operating Officer and President
Productsgeneric drugs,Pharmaceutical drugs


  • Maple Grove, Minnesota: Corporate Headquarters[3]
  • Morristown, New Jersey: Corporate Office[3]
  • Plymouth, Minnesota: Manufacturing[3]


Founded in 1919 as a maker of digitalis drugs,[4] Upsher-Smith has traditionally focused on the manufacture of generic medications. In 2017, after owning and operating Upsher-Smith for 47 years, the Evenstad family made the decision to sell the largest part of their company, the generics business, to Sawai Pharmaceutical Co., Ltd., a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.[5]

Upsher-Smith’s non-generic pharmaceuticals businesses Proximagen, Pairnomix and MOBĒ remained with ACOVA, a holding company owned by the Evenstads.


Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:[7]


  1. ^ "Taku Nakaoka Named CEO of Upsher-Smith Laboratories".
  2. ^ "Executive Team".
  3. ^ a b c d "Locations - Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  4. ^ a b "Upsher-Smith History".
  5. ^ "Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business". May 31, 2017.
  6. ^ "Products A-Z - Upsher-Smith". Upsher-Smith Laboratories, LLC. Retrieved 2022-06-21.
  7. ^ "Upsher-Smith Products".